Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Innovation Council · Running

OPERAS Opioid-free Pain relief for Enhanced Recovery After Spine fixation surgery

Coordinator
Sentryx BV, Netherlands
Runs
1 April 2023 to 31 March 2026
Status
Running
EU funding
€2.5m
Total cost
€5.7m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190122961

What the project is doing

In the project's own words, from its summary on CORDIS.

There is a troubling lack of effective pain treatments after major surgery. Especially after musculoskeletal procedures, patients experience debilitating pain now treated with opioids. Opioids provide insufficient pain relief, have many toxic side-effects, and are highly addictive. Pain and opioid-related side-effects impede early mobilisation and recovery and are the primary reasons for extended hospital stays. SentryX is developing revolutionary drug delivery technology to extend the effects of a well-established local pain blocker called bupivacaine.

Its initial use case in spine fixation surgery, Bupi-Ring, delivers bupivacaine directly to the surgical site for more than 72 hours without changing the existing surgical workflow. Non-opioid local pain relief in this critical early phase of recovery will promote early mobilisation, shorten hospital stays, prevent complications, and save costs. This project will demonstrate Bupi-Ring’s safety and efficacy in humans for the first time.

Topics

Who is involved

OrganisationCityCountryRole
Sentryx BVAusterlitzNetherlandsCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI